FDA Grants Full Approval of Moderna’s Spikevax COVID Vaccine — Another ‘Bait-and-Switch?’

The U.S. Food and Drug Administration on Monday granted full approval of Moderna’s Spikevax COVID vaccine for people 18 and older. Similar to the agency’s licensing last year of Pfizer’s Comirnaty vaccine, the approval raised a number of legal questions.